Adherence to PoNS device key to improving walking in MS: Study
Oct 10, 2024 · That’s according to early data from PoNSTEP (NCT05437276), a real-world study that’s testing how adherence to the 14-week PoNS therapy regimen reflects on changes in gait, or walking ability ...
ECTRIMS 2024: McDonald criteria changes could speed diagnoses
Sep 25, 2024 · December 23, 2024 News by Esteban Domínguez Cerezo, MS. Steady rise in MS seen among adults older than age 50 in Italy. October 31, 2024 News by Lindsey Shapiro, PhD.
Let’s talk facts about MS and COVID-19 vaccines – Multiple...
Jun 2, 2023 · Ed Tobias People say to write what you know and Ed Tobias knows about MS. He's lived with the illness since 1980, when he was 32 years old. Ed's a retired, award-winning broadcast journalist and ...
Multiple Sclerosis News Today | Symptoms, Diagnosis, Treatments
Top 10 MS news stories of 2024 The team at Multiple Sclerosis News Today has brought our audience the latest news about treatments, scientific research, and clinical trials in multiple sclerosis ...
New twin study implicates certain T-cells in early MS inflammation
Oct 9, 2024 · July 30, 2024 News by Marisa Wexler, MS Inflammation outside the brain linked to faster MS progression Study examined CD8 T-cells in 12 pairs of identical twins
How the symptoms of multiple sclerosis affect my hands
Nov 18, 2024 · The opinions expressed in this column are not those of Multiple Sclerosis News Today or its parent company, Bionews, and are intended to spark discussion about issues pertaining to multiple sclerosis.
Study: MS fatigue can be eased with both modafinil and talk therapy
Oct 21, 2024 · Medicine, talk therapy for fatigue. To find out, the University of Michigan sponsored a clinical trial called COMBO-MS (NCT03621761) that enrolled 336 adults with MS-related fatigue that had been ...
About Us - Multiple Sclerosis News Today
Multiple Sclerosis News Today is a digital platform intended to provide the multiple sclerosis (MS) community with the most recent news and information on MS, as well as first-hand community ...
Tecfidera with immune tolerizing cell therapy shows promise for MS
October 8, 2024 News by Esteban Domínguez Cerezo, MS. Nerve stimulator for myelin repair to enter RRMS clinical trial. TolDC therapy found safe, feasible in 2 Phase 1 clinical trials.
New study gives snapshot of MS in US by race, age, sex, location
May 19, 2023 · March 3, 2021 News by Marisa Wexler, MS #ACTRIMS2021 – Research Finds Race- and Ethnicity-based Differences in MS Therapies Researchers call for better care of ‘historically underrecognized ...